Show simple item record

Molecular and preclinical basis to inhibit PGE2 receptors EP2 and EP4 as a novel nonsteroidal therapy for endometriosis

dc.creatorArosh, Joe
dc.creatorLee, JeHoon
dc.creatorBalasubbramanian, Dakshnapriya
dc.creatorStanley, Jone
dc.creatorLong, Charles
dc.creatorMeagher, Mary
dc.creatorOsteen, Kevin
dc.creatorBruner-Tran, Kaylon
dc.creatorBurghardt, Robert
dc.creatorStarzinski-Powitz, Anna
dc.creatorBanu, Sakhila
dc.date.accessioned2019-10-09T18:49:31Z
dc.date.available2019-10-09T18:49:31Z
dc.date.issued2015
dc.identifier.issn0027-8424
dc.identifier.issn0744-2831
dc.identifier.issn1091-6490
dc.identifier.urihttps://hdl.handle.net/1969.1/181162
dc.format.extent1en
dc.publisherProceedings of the National Academy of Sciences of the United States of America
dc.relation.ispartof1foldr Import 2019-10-08 Batch 6en
dc.relation.uri10.1073/pnas.1507931112en
dc.titleMolecular and preclinical basis to inhibit PGE2 receptors EP2 and EP4 as a novel nonsteroidal therapy for endometriosisen


Files in this item

Thumbnail
Name:
document-1.pdf
Size:
1.925Mb
Format:
PDF
View/ Open

This item appears in the following Collection(s)

Show simple item record